M.Sc.

Microbiology
Bio Technology

https://www.mmumullana.org/course/m-sc-microbiology
 M.Sc. Microbiology
Bio Technology

https://www.mmumullana.org/course/m-sc-microbiology

Using the Pitchbook Template

SAMPLE SLIDES
  Market Risk  Fiscal Year 2005 Annual Report

1st 2nd 3rd 4th

2004 2005 Average Quarter Ended Qtr. Qtr. Qtr. Qtr. Total
200 Fiscal year 2003
150 $7,74 $8,54 $7,83
Revenue 6 1 5 $8,065 $32,187
100 Gross profit 6,402 6,404 6,561 6,761 26,128
50 Net income 2,041 1,865 2,142 1,483 7,531
Basic earnings per
0
Interest rates Currency rates Equity prices Commodity share 0.19 0.17 0.2 0.14 0.7
prices Diluted earnings per
 Fiscal Year 2004 share 0.19 0.17 0.2 0.14 0.69
Fiscal year 2004
$8,21 $10,1 $9,17
Revenue 5 53 5 $9,292 $36,835
25% 22% 1st Qtr Gross profit 6,735 7,809 7,764 7,811 30,119
2nd Qtr Net income 2,614 1,549 1,315 2,690 8,168
3rd Qtr Basic earnings per
25% 28%
4th Qtr share 0.24 0.14 0.12 0.25 0.76
Diluted earnings per
share 0.24 0.14 0.12 0.25 0.75
Fiscal year 2005
$9,18 $10,8 $9,62 $10,16
Revenue 9 18 0 1 $39,788
Gross Profit Net Revenue Gross profit 7,720 8,896 8,221 8,751 33,588
Net income 2,528 3,463 2,563 3,700 12,254
10000
Basic earnings per
8000 share 0.23 0.32 0.24 0.34 1.13
6000 Diluted earnings per

Annual Report
4000 share 0.23 0.32 0.23 0.34 1.12
2000
(1) Includes charges totaling $750 million (pre-tax) related to the
0 Fabrikam settlement and $1.15 billion in impairments of investments.
1st Qtr 2nd Qtr 3rd Qtr 4th Qtr (2) Includes stock-based compensation charges totaling $2.2 billion for the
employee stock option transfer program.
(3) Includes charges totaling $756 million (pre-tax) related to Contoso
subsidiaries and other matters.
  1st Year Sales Figures  Market Distribution

East West North East West North

180 100
90
80
160 70
60
50
140 40
30
20
120
10
0
100 1st Qtr 2nd Qtr 3rd Qtr 4th Qtr
 Financial Summary

80  Our perennial 3rd Quarter boost was

larger than expected contributing to
an exceptionally strong year.
60
Distribution of sales across the
geographic markets looks fairly
40 steady.

20
 Our new product line, released this
year, is early in its adoption phase. We
Market Summary Analysis
0
1st Qtr 2nd Qtr 3rd Qtr 4th Qtr
expect to see substantial revenue
contribution from these products over
the next two years.
  Market Share by Division  Business Process Model

Product Division 2002 2003 2004 2005

Electronics 10.3 % 12.1% 13.2% 17.0% Operat

ing
Consumer Goods 1.3% 2.3% 2.2% 2.7%

Services 12.0% 11.0% 8.9% 9.2%

Widget Sales 78.0% 82.3% 82.5% 84.0%

Installations 5.3% 7.9% 12.2% 15.1% Changi Suppo

ng rting
(1)Percentages based on domestic comparison to competitors in
directly related industries.
(2)Percentages based on standing at the end of each fiscal year.
(3)Values provided by a third party agency.

Optimi
zing

 Organizational Structure  Summary

 This has been a pivotal year for the

company in growth, but also
development of our infrastructure and
Contoso business processes. We’ll continue to
focus on our internal systems over the
next year.

Human  Specific growth areas include Electronics

Fina
Product
Development Resources where Contoso has seen as 6.7%

Business Summary
increase in market share over the last
De
nce three years. An area to monitor closely is
Qual
Man
ity
Head Subsi
ufac
si turi
Ass quart diarie the Services division where market share
uran
gn ng ce ers s
has dropped slightly.